GAD antibodies were subsequently shown to be present in the sera of up to 60% of patients with SPS, 80% of patients with IDDM (at a much lower titre than SPS), in patients with polyendocrine autoimmune syndromes and in some cases of sporadic, otherwise idiopathic ataxia [7–11]. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.